Research Peptides

Bradykinin

Bradykinin is a nine-amino acid peptide formed from high-molecular-weight kininogen by the action of kallikrein. It is a potent mediator of inflammation, vasodilation, vascular permeability, and pain. Acting through B1 and B2 receptors, it plays important roles in cardiovascular regulation, inflammation, and nociception.

Technical Specifications

Sequence / StructureArg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg
Molecular Weight1060.21 g/mol
Purity>=98%
AppearanceWhite lyophilized powder
StorageStore at -20C, reconstituted at 2-8C
SolubilitySoluble in water

Application Areas

  • Inflammation research
  • Vasodilation studies
  • Pain signaling
  • Kinin-kallikrein system
  • Vascular permeability
  • Cardiovascular pharmacology

Published Research on Bradykinin

Regoli D, Barabe J. (1980) — Pharmacology of bradykinin and related kinins. Pharmacol Rev. DOI: 32(1):1-46

Marceau F, Regoli D. (2004) — Bradykinin receptor ligands: therapeutic perspectives. Nat Rev Drug Discov. DOI: 10.1038/nrd1522

Leeb-Lundberg LM, Marceau F, Muller-Esterl W, et al. (2005) — International Union of Pharmacology. XLV. Classification of the kinin receptor family. Pharmacol Rev. DOI: 10.1124/pr.57.1.7

Frequently Asked Questions About Bradykinin

A nonapeptide mediator of inflammation, vasodilation, and pain, formed from kininogen by kallikrein.

Acts through B1 (inducible, inflammation) and B2 (constitutive, acute effects) kinin receptors.

>=98% with full analytical documentation.

Inflammation, pain research, cardiovascular pharmacology, vascular permeability, and kinin-kallikrein studies.

Lyophilized at -20C, reconstituted at 2-8C.

Yes, wholesale quantities with volume discounts.

Related Research Peptides

Request Price List